Largest biotech companies in the United States by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Amgen leads the 10 biotech companies in the United States ranked by total debt, at DKK 371.9B, ahead of Gilead Sciences (DKK 169.9B) and Biogen (DKK 42.8B). Figures as of 20 Nov 2026, 17:58 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
10
First
AmgenDKK 371.9B
Median
DKK 3.9B
Combined market value
DKK 5T
Countries
1
Not ranked
10no total debt on file

Market values as of .

United States
All sectors
Biotech
DKK
Clear filters
Largest biotech companies in the United States by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareDKK 371.9BDKK 1.62TDKK 2,993.67 0.73% up 30% up United States
2Gilead SciencesGILD · Health CareDKK 169.9BDKK 1.42TDKK 1,147.54 1.16% up 31% up United States
3BiogenBIIB · Health CareDKK 42.8BDKK 251.3BDKK 1,700.23 1.00% up 41% up United States
4Halozyme TherapeuticsHALO · Health CareDKK 14.6BDKK 72.3BDKK 633.88 0.02% up 32% up United States
5ModernaMRNA · Health CareDKK 4BDKK 538.6BDKK 1,331.15 1.96% down 740% up United States
6RepligenRGEN · Health CareDKK 3.7BDKK 71.6BDKK 1,120.29 3.42% down 5% up United States
7Bio-TechneTECH · Health CareDKK 1.4BDKK 77.8BDKK 495.37 0.03% up 18% up United States
8Adaptive BiotechnologiesADPT · Health CareDKK 893.7MDKK 30.5BDKK 188.61 1.28% down 51% up United States
9Scholar Rock HoldingSRRK · Health CareDKK 679.2MDKK 41.7BDKK 341.80 0.38% down 25% up United States
10CG OncologyCGON · Health CareDKK 20.4MDKK 48.8BDKK 546.08 2.11% down 93% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8115 DKK). 10 companies have no total debt on file and are not ranked here.

Questions and answers

Which biotech companies in the United States rank first by total debt?

Amgen (DKK 371.9B), Gilead Sciences (DKK 169.9B) and Biogen (DKK 42.8B) are the top three of the 10 biotech companies in the United States ranked by total debt as of 20 Nov 2026, 17:58 UTC.

How many biotech companies in the United States are in this ranking?

10 are ranked by total debt. 10 more have no total debt on file and are left out rather than ranked at zero.

What are these biotech companies in the United States worth together?

The 10 biotech companies in the United States ranked by total debt have a combined market value of DKK 5T as of 20 Nov 2026, 17:58 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest biotech companies in the United States by total debt”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.